Zacks Small Cap Research
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted
📊
AI Sentiment
Positive
7/10
- Home
- ORMP
as of 11-28-2025 12:26pm EST
$2.88
+$0.03
+1.05%
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Chart Type:
Time Range:
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 104.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 260.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.03 | EPS Growth: | 838.25 |
| 52 Week Low/High: | $1.82 - $3.09 | Next Earning Date: | 11-13-2025 |
| Revenue: | $2,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered ORMP Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 64.75%
64.75%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Oramed Pharmaceuticals Inc. News
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
Compare ORMP vs Leading Stocks
See how ORMP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.